- Type / Class
- Equity / Common Stock
- Shares outstanding
- 28,736,767
- Total 13F shares
- 30,101,297
- Share change
- -1,454,827
- Total reported value
- $3,243,312,025
- Put/Call ratio
- 140%
- Price per share
- $107.74
- Number of holders
- 265
- Value change
- -$145,765,886
- Number of buys
- 150
- Number of sells
- 112
Quarterly Holders Quick Answers
What is CUSIP 81663L200?
CUSIP 81663L200 identifies WGS - GeneDx Holdings Corp. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81663L200:
Top shareholders of WGS - GeneDx Holdings Corp. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CMLS Holdings LLC |
13D/G
|
Keith A. Meister |
12%
|
3,630,826
|
$375,826,799 | -$48,159,994 | 22 Aug 2025 | |
| Casdin Capital, LLC |
3/4/5
13F
|
Director, 10%+ Owner · Company |
11%
|
3,027,682
|
$365,701,673 | -$60,451,950 | 22 Aug 2025 | |
| Eli Casdin |
3/4/5
|
Director, 10%+ Owner |
14%
|
3,880,073
|
$337,217,143 | — | 18 Jun 2025 | |
| Corvex Management LP |
13F
3/4/5
|
Company · Director, 10%+ Owner |
11%
|
3,058,629
|
$282,342,043 | — | 30 Jun 2025 | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
3/4/5
13D/G
|
10%+ Owner |
4.9%
from 13D/G
|
2,719,692
|
$192,487,561 | — | 15 Nov 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
13D/G
|
Company |
4.3%
from 13D/G
|
1,631,402
|
$150,594,719 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5%
|
1,434,634
|
$132,431,066 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
|
THE GOLDMAN SACHS GROUP, INC. · Company |
3.9%
|
1,106,752
|
$122,860,496 | -$34,984,913 | 31 Mar 2025 | |
| Pentwater Capital Management LP |
13F
|
Company |
4.2%
|
1,220,000
|
$112,618,200 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
1,180,923
|
$109,011,002 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.6%
|
1,037,116
|
$95,737,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
1,051,308
mixed-class rows
|
$92,472,343 | — | 30 Jun 2025 | |
| OPKO HEALTH, INC. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,646,972
|
$91,295,123 | — | 15 Aug 2024 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
3.2%
|
922,454
|
$85,151,729 | — | 30 Jun 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
2.9%
|
820,523
|
$75,742,478 | — | 30 Jun 2025 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13D/G
13F
|
Company |
3%
|
867,265
|
$75,374,001 | -$48,643,788 | 30 Jun 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.1%
|
589,188
|
$54,387,944 | — | 30 Jun 2025 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
2%
|
586,100
|
$54,102,891 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.9%
|
554,419
|
$51,178,418 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
487,070
|
$44,961,462 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
484,714
|
$44,749,671 | — | 30 Jun 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.5%
|
434,472
|
$40,106,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
415,996
|
$38,400,591 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
1.4%
|
413,223
|
$38,144,616 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
406,573
|
$37,530,753 | — | 30 Jun 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.4%
|
397,896
|
$36,729,780 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
386,758
|
$35,701,631 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
337,427
|
$31,147,849 | — | 30 Jun 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
326,677
|
$30,155,554 | — | 30 Jun 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.1%
|
317,871
|
$29,343,000 | — | 30 Jun 2025 | |
| Science & Technology Partners, L.P. |
13F
|
Company |
1.1%
|
317,276
|
$29,287,748 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
303,455
|
$28,011,931 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.95%
|
272,227
|
$25,129,274 | — | 30 Jun 2025 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
0.94%
|
271,233
|
$25,037,518 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.89%
|
255,931
|
$23,625,041 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.82%
|
235,085
|
$21,700,696 | — | 30 Jun 2025 | |
| Alamea Verwaltungs GmbH |
13F
|
Company |
0.78%
|
223,989
|
$20,676,425 | — | 30 Jun 2025 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.77%
|
221,610
|
$20,456,819 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
214,984
|
$19,845,172 | — | 30 Jun 2025 | |
| Blackstone Tactical Opportunities Fund - FD L.P. |
3/4/5
|
10%+ Owner |
0.35%
|
100,000
|
$16,752,000 | — | 22 Jul 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.61%
|
175,000
|
$16,154,250 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.6%
|
172,383
|
$15,912,671 | — | 30 Jun 2025 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
0.6%
|
171,526
|
$15,833,565 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
167,603
|
$15,471,433 | — | 30 Jun 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
0.6%
from 13D/G
|
163,324
|
$15,076,425 | — | 30 Jun 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.57%
|
162,900
|
$15,037,299 | — | 30 Jun 2025 | |
| Portolan Capital Management, LLC |
13F
|
Company |
0.56%
|
162,228
|
$14,975,267 | — | 30 Jun 2025 | |
| Jason Ryan |
3/4/5
|
Director |
0.4%
|
115,188
|
$14,971,290 | -$4,995,801 | 27 Aug 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.54%
|
156,226
|
$14,421,223 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.48%
|
136,732
|
$12,621,731 | — | 30 Jun 2025 |
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2025
As of 30 Sep 2025,
GeneDx Holdings Corp. - Common Stock (WGS) was held by
265 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,101,297 shares.
The largest 10 holders included
Corvex Management LP, Casdin Capital, LLC, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, ORACLE INVESTMENT MANAGEMENT INC, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, T. Rowe Price Investment Management, Inc., and FRANKLIN RESOURCES INC.
This page lists
266
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
227
Q3 2025 holders
265
Holder diff
38
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.